← Back to all trials
Completed
NCT05959954
Predicting Nociplastic Pain in Carpal Tunnel Syndrome Through Quantitative Sensory Testing
Conditions: Carpal Tunnel Syndrome, Chronic Pain
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Enrollment: 229
Sponsor: Ahram Canadian University
Location: Outpatient clinic of faculty of physical therapy, Ahram Canadian University Al Ḩayy Ath Thāmin Giza Governorate
Summary
This prospective observational study will examine whether sensory testing performed at study entry can help predict the pain pattern present 12 months later in adults with carpal tunnel syndrome (CTS). Adults with clinically and electrodiagnostically confirmed CTS will undergo baseline clinical assessment, questionnaires, nerve-conduction testing, pain-phenotype classification, and quantitative sensory testing (QST). The main QST measures will assess pressure-pain sensitivity at a site away from the affected hand, temporal summation of pain, and conditioned pain modulation. Participants will receive their usual clinical care; the study will not assign treatment. They will be reassessed at 6 and 12 months. The main outcome is whether the participant has a predominantly neuropathic CTS pain phenotype or a mixed neuropathic-nociplastic pain phenotype at 12 months. Follow-up phenotype assessors will not have access to baseline QST results. The study hypothesis is that baseline QST will provide prognostic information beyond standard clinical and electrodiagnostic characteristics.
Eligibility Criteria
Inclusion Criteria:
* Adults ages 18-60
* Clinical diagnosis of CTS based on presence of parasthesias and/or pain in median nerve distribution, positive Phalen's test and/or Tinel's sign, and nocturnal symptoms
* Electrodiagnostic evidence of median neuropathy at the wrist:
1. Prolonged median motor distal latency \>4.2 ms
2. Prolonged median sensory latency \>3.4 ms
* Symptom duration between 6 months and 2 years (to exclude very early or very late stages)
* Pain severity of ≥5 on 0-10 numerical rating scale
* No evidence of thenar muscle atrophy on physical exam
* No prior surgery or fracture of the affected wrist
* No evidence of comorbid diabetes mellitus, cervical radiculopathy, polyneuropathy, or other neuromuscular disorders
Exclusion Criteria:
* Diabetes mellitus, as a common cause of polyneuropathy, which can confound QST measures.
* Cervical radiculopathy or other upper limb neuropathies, which can cause overlapping sensory symptoms and signs.
* History of wrist fracture or surgery, which may cause structural abnormalities affecting nerve function.
* Pregnancy, due to physiological changes that can affect nerve function.
* Patients with severe thenar muscle atrophy, indicating long-standing severe median neuropathy.
* Patients unable to provide informed consent or comply with study procedures.
Source: ClinicalTrials.gov (NCT05959954). StuddyBuddy aggregates publicly available trial information.